Osteoarthritis is a common cause of disability worldwide. Although commonly referred to as
a disease of the joint cartilage, osteoarthritis affects all joint tissues equally. The …

Being the most common musculoskeletal progressive condition, osteoarthritis is an
interesting target for research. It is estimated that the prevalence of knee osteoarthritis (OA) …

Background: Intra-articular microfragmented adipose tissue (MF-AT) injections have been
proposed for the treatment of knee osteoarthritis (OA). Purpose: To compare a single …

Osteoarthritis is the most common musculoskeletal progressive disease, with the knee as
the most commonly affected joint in the human body. While several new medications are still …

Background: While many reviews have been performed to attempt to provide conclusive
evidence regarding the outcomes of mesenchymal stem cells (MSCs) in osteoarthritis …

Background: Regenerative cell therapies, such as adipose-derived stromal vascular fraction
(SVF), have been postulated as potential treatments for knee osteoarthritis (KOA) …

Osteoarthritis (OA) is a degenerative disorder associated with cartilage loss and is a leading
cause of disability around the world. In old age, the capacity of cartilage to regenerate is …

Background and Objectives: Knee osteoarthritis (OA) is a widespread joint disease, set to
increase due to aging and rising obesity. Beyond cartilage degeneration, OA involves the …

Osteoarthritis (OA) is a widely prevalent disease worldwide, and with an increasingly ageing
society, it has become a challenge for the field of regenerative medicine. OA is a disease …

Purpose Current conservative treatments for knee OA provide limited benefits, with
symptoms relief for a short amount of time. Regenerative medicine approaches such as the …